User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 3 results.
    • Journal article
    Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study.
    Morschhauser, Franck Le Gouill, Steven Feugier, Pierre Bailly, Sarah[UCL] Nicolas-Virelizier, Emmanuelle Bijou, Fontanet Salles, Gilles A Tilly, Hervé Fruchart, Christophe Van Eygen, Koen Snauwaert, Sylvia Bonnet, Christophe Haioun, Corinne Thieblemont, Catherine Bouabdallah, Reda Wu, Ka Lung Canioni, Danielle Meignin, Véronique Cartron, Guillaume Houot, Roch (2019) The Lancet. Haematology — Vol. 6, no.8, p. e429-e437 (2019)
    • Journal article
    Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study.
    Houot, Roch Cartron, Guillaume Bijou, Fontanet de Guibert, Sophie Salles, Gilles A Fruchart, Christophe Bouabdallah, Krimo Maerevoet, Marie Feugier, Pierre Le Gouill, Steven Tilly, Hervé Casasnovas, Rene-Olivier Moluçon-Chabrot, Cécile Van Den Neste, Eric[UCL] Zachee, Pierre André, Marc[UCL] Bonnet, Christophe Haioun, Corinne Van Hoof, Achiel Van Eygen, Koen Molina, Lysiane Nicolas-Virelizier, Emmanuelle Ruminy, Philippe Morschhauser, Franck (2019) Leukemia — Vol. 33, no. 3, p. 776-780 (2019)
    • Journal article
    Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
    Bachy, Emmanuel Houot, Roch Feugier, Pierre Bouabdallah, Krimo Bouabdallah, Reda Virelizier, Emmanuelle Nicolas Maerevoet, Marie Fruchart, Christophe Snauwaert, Sylvia Le Gouill, Steven Marolleau, Jean-Pierre Molina, Lysiane Moluçon-Chabrot, Cécile Thieblemont, Catherine Tilly, Hervé Bijou, Fontanet Haioun, Corinne Van Den Neste, Eric[UCL] Fabiani, Bettina Meignan, Michel Cartron, Guillaume Salles, Gilles Casasnovas, Olivier Morschhauser, Franck (2022) Blood — Vol. 139, no. 15, p. 2338-2346 (2022)